Fake Xanax anxiety pills from China seized in Zurich

A sample of the counterfeit drugs seized by Swiss customs officials Experts think it would be hard to spot the drugs are fake at first glance

Related Stories

Customs agents have seized one million fake anti-anxiety pills in transit at Zurich airport, Swiss officials say.

The four-crate shipment was on its way from China to Egypt, the Swiss Agency for Therapeutic Products said.

The tablets are counterfeit versions of Xanax - a drug manufactured by Pfizer to treat severe anxiety or panic disorder.

Tests showed the drugs contained no active ingredients, but would be very difficult to recognise as fakes.

The counterfeit drugs were packed into four crates which weighed over 400kg, said the agency, also known as Swissmedic.

"Analyses in the Swissmedic laboratory revealed that the drugs, which are prescribed to treat symptoms of acute anxiety, contained no active ingredients whatsoever," Swissmedic said in a statement, adding that they were being destroyed.

"According to experts, the drugs would be unrecognisable as counterfeits at first glance."

Developing countries such as Egypt are considered a major market for the multi-billion dollar trade in fake drugs.

The World Health Organization says many countries in Africa, and parts of Asia and Latin America, have areas where more than 30% of medicines on sale can be counterfeit.

Counterfeit medication ranges from painkillers to treatment for life-threatening conditions, it says,

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Europe stories

RSS

Features & Analysis

Elsewhere on the BBC

  • HobbitHobbit review

    Nicholas Barber asks whether The Battle of the Five Armies is worthwhile or unnecessary

Programmes

  • Digital candlesClick Watch

    Inside the 'Harry Potter' church, using technology to explore "digital empathy".

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.